Aquestive Therapeutics Inc Cash Flow Quality Index

Latest as of March 2023: 1.09x

Aquestive Therapeutics Inc cash flow quality index. Aquestive Therapeutics Inc (AQST) has a Cash Flow Quality Index of 1.09x as of March 2023. Operating cash flow of $8.82 Million exceeds net income of $8.07 Million, indicating high earnings quality where cash backs reported profits. See how financially flexible is Aquestive Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.09x
Operating CF / Net Income

Operating Cash Flow

$8.82 Million
USD

Net Income

$8.07 Million
USD

Data as of

Mar 2023
Most recent filing

Aquestive Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Aquestive Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Aquestive Therapeutics Inc. For the full cash flow conversion analysis, see Aquestive Therapeutics Inc operating cash flow efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.